Clinical Study

Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study

Table 2

Modifiable and nonmodifiable risk factors for developing PTDM including nontransplant-related variables.

Nontransplant variables
PTDM (+)
()
PTDM (-)
()
OR95% CI
InferiorUpper

Recipient age (years)0.0011.041.021.07
Male (%, )62.3% (38)51.5% (232)0.690.890.511.56
Non-black (%, )52.5% (32)52.9% (206)0.940.980.571.68
RRT (%, )96.7% (59)92% (358)0.210.390.091.68
Mean time on dialysis (months)44.645.10.210.990.991.00
ADPKD (%, )11.5% (7)9% (35)0.540.760.321.80
Pretransplant hyperglycaemia (%, )36% (22)23.1% (90)0.0320.530.300.95
Living donor (%, )45.9% (28)41.6% (162)0.530.840.491.45
Positive CMV serology (%, )85.2% (52)87.9% (342)0.521.290.562.79
(%, )57.4% (35)27.7% (108)0.00013.502.016.09
HLA DR3 (%, )11.5% (7)20% (78)0.121.930.854.42
HLA A2 (%, )57.3% (35)50.1% (195)0.290.750.431.29
HLAB35 (%, )18% (11)23.6% (92)0.331.410.702.82
HLADR4 (%, )27.8% (17)21.3% (83)0.260.700.381.29
HLADR7 (%, )29.5% (18)22.8% (89)0.260.710.391.29
HLADR11 (%, )27.8% (17)26.4% (103)0.820.930.511.70
HLADR13 (%, )32.7% (20)27% (105)0.350.760.421.35